Decoy receptor 3 protects non-obese diabetic mice from autoimmune diabetes by regulating dendritic cell maturation and function

Molecular Immunology

Volumn 47, Issue 16, 2010, Pages 2552-2562

  Wang, Yen Ling ^a   Chou, Feng Cheng ^a   Sung, Hsiang Hsuan ^a   Fan, Pao Luo ^c   Hsueh, Chao Wen ^c   Lin, Wen Chi ^a   Chen, Shyi Jou ^b   Lin, Wan Wan ^d   Sytwu, Huey Kang ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Decoy receptor 3; Helper T cells; Type 1 diabetes

Indexed keywords

CELL SURFACE MARKER; DECOY RECEPTOR 3; GAMMA INTERFERON; INTERLEUKIN 4; RECOMBINANT DECOY RECEPTOR 3; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL TYPE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DIABETES MELLITUS; IMMUNOREGULATION; INSULITIS; LYMPHOCYTE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; TH1 CELL; TH2 CELL; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; CELL POLARITY; CELLS, CULTURED; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; FEMALE; MALE; MICE; MICE, INBRED NOD; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; SPLEEN; T-LYMPHOCYTES, HELPER-INDUCER;

MURINAE; MUS;

EID: 78649328400     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.07.001     Document Type: Article

References (46)

1. An M.M., Fan K.X., Cao Y.B., Shen H., Zhang J.D., Lu L., Gao P.H., Jiang Y.Y. Lymphtoxin beta receptor-Ig protects from T-cell-mediated liver injury in mice through blocking LIGHT/HVEM signaling. Biol. Pharm. Bull. 2006, 29:2025-2030.
2. Arima T., Rehman A., Hickey W.F., Flye M.W. Inhibition by CTLA4Ig of experimental allergic encephalomyelitis. J. Immunol. 1996, 156:4916-4924.
3. Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer 2002, 2:420-430.
4. Bai C., Connolly B., Metzker M.L., Hilliard C.A., Liu X., Sandig V., Soderman A., Galloway S.M., Liu Q., Austin C.P., Caskey C.T. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1230-1235.
5. Chakravarti S., Sabatos C.A., Xiao S., Illes Z., Cha E.K., Sobel R.A., Zheng X.X., Strom T.B., Kuchroo V.K. Tim-2 regulates T helper type 2 responses and autoimmunity. J. Exp. Med. 2005, 202:437-444.
6. Chang Y.C., Chan Y.H., Jackson D.G., Hsieh S.L. The glycosaminoglycan-binding domain of decoy receptor 3 is essential for induction of monocyte adhesion. J. Immunol. 2006, 176:173-180.
7. Charlton B., Lafferty K.J. The Th1/Th2 balance in autoimmunity. Curr. Opin. Immunol. 1995, 7:793-798.
8. Chen S.J., Wang Y.L., Kao J.H., Wu S.F., Lo W.T., Wu C.C., Tao P.L., Wang C.C., Chang D.M., Sytwu H.K. Decoy receptor 3 ameliorates experimental autoimmune encephalomyelitis by directly counteracting local inflammation and downregulating Th17 cells. Mol. Immunol. 2009, 47:567-574.
9. Delovitch T.L., Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997, 7:727-738.
10. Emamaullee J.A., Davis J., Merani S., Toso C., Elliott J.F., Thiesen A., Shapiro A.M. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 2009, 58:1302-1311.
11. Gommerman J.L., Mackay F., Donskoy E., Meier W., Martin P., Browning J.L. Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway. J. Clin. Invest. 2002, 110:1359-1369.
12. Green D.R. Apoptosis. Death deceiver. Nature 1998, 396:629-630.
13. Han S., Zhang X., Marinova E., Ozen Z., Bheekha-Escura R., Guo L., Wansley D., Booth G., Fu Y.X., Zheng B. Blockade of lymphotoxin pathway exacerbates autoimmune arthritis by enhancing the Th1 response. Arthritis Rheum. 2005, 52:3202-3209.
14. Hsu T.L., Chang Y.C., Chen S.J., Liu Y.J., Chiu A.W., Chio C.C., Chen L., Hsieh S.L. Modulation of dendritic cell differentiation and maturation by decoy receptor 3. J. Immunol. 2002, 168:4846-4853.
15. Hsu T.L., Wu Y.Y., Chang Y.C., Yang C.Y., Lai M.Z., Su W.B., Hsieh S.L. Attenuation of Th1 response in decoy receptor 3 transgenic mice. J. Immunol. 2005, 175:5135-5145.
16. Hung J.T., Liao J.H., Lin Y.C., Chang H.Y., Wu S.F., Chang T.H., Kung J.T., Hsieh S.L., McDevitt H., Sytwu H.K. Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model. J. Autoimmun. 2005, 25:181-192.
17. Jain R., Tartar D.M., Gregg R.K., Divekar R.D., Bell J.J., Lee H.H., Yu P., Ellis J.S., Hoeman C.M., Franklin C.L., Zaghouani H. Innocuous IFNgamma induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J. Exp. Med. 2008, 205:207-218.
18. Ka S.M., Sytwu H.K., Chang D.M., Hsieh S.L., Tsai P.Y., Chen A. Decoy receptor 3 ameliorates an autoimmune crescentic glomerulonephritis model in mice. J. Am. Soc. Nephrol. 2007, 18:2473-2485.
19. Kabashima K., Banks T.A., Ansel K.M., Lu T.T., Ware C.F., Cyster J.G. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 2005, 22:439-450.
20. Kawasaki E., Abiru N., Eguchi K. Prevention of type 1 diabetes: from the view point of beta cell damage. Diabetes Res. Clin. Pract. 2004, 66(Suppl. 1):S27-S32.
21. Levisetti M.G., Suri A., Frederick K., Unanue E.R. Absence of lymph nodes in NOD mice treated with lymphotoxin-beta receptor immunoglobulin protects from diabetes. Diabetes 2004, 53:3115-3119.
22. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999, 223:77-92.
23. Mackay F., Browning J.L. Turning off follicular dendritic cells. Nature 1998, 395:26-27.
24. Meyers J.H., Chakravarti S., Schlesinger D., Illes Z., Waldner H., Umetsu S.E., Kenny J., Zheng X.X., Umetsu D.T., DeKruyff R.H., Strom T.B., Kuchroo V.K. TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nat. Immunol. 2005, 6:455-464.
25. Migone T.S., Zhang J., Luo X., Zhuang L., Chen C., Hu B., Hong J.S., Perry J.W., Chen S.F., Zhou J.X., Cho Y.H., Ullrich S., Kanakaraj P., Carrell J., Boyd E., Olsen H.S., Hu G., Pukac L., Liu D., Ni J., Kim S., Gentz R., Feng P., Moore P.A., Ruben S.M., Wei P. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002, 16:479-492.
26. Mueller A.M., Pedre X., Killian S., David M., Steinbrecher A. The decoy receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid. J. Neuroimmunol. 2009, 209:57-64.
27. Nicholson L.B., Kuchroo V.K. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr. Opin. Immunol. 1996, 8:837-842.
28. Pierer M., Schulz A., Rossol M., Kendzia E., Kyburz D., Haentzschel H., Baerwald C., Wagner U. Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model. J. Immunol. 2009, 182:3139-3145.
29. Pitti R.M., Marsters S.A., Lawrence D.A., Roy M., Kischkel F.C., Dowd P., Huang A., Donahue C.J., Sherwood S.W., Baldwin D.T., Godowski P.J., Wood W.I., Gurney A.L., Hillan K.J., Cohen R.L., Goddard A.D., Botstein D., Ashkenazi A. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998, 396:699-703.
30. Roth W., Isenmann S., Nakamura M., Platten M., Wick W., Kleihues P., Bahr M., Ohgaki H., Ashkenazi A., Weller M. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res. 2001, 61:2759-2765.
31. Shi G., Luo H., Wan X., Salcedo T.W., Zhang J., Wu J. Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 2002, 100:3279-3286.
32. Sung H.H., Juang J.H., Lin Y.C., Kuo C.H., Hung J.T., Chen A., Chang D.M., Chang S.Y., Hsieh S.L., Sytwu H.K. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J. Exp. Med. 2004, 199:1143-1151.
33. Sutherland A.P., Van Belle T., Wurster A.L., Suto A., Michaud M., Zhang D., Grusby M.J., von Herrath M. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 2009, 58:1144-1155.
34. Tamada K., Shimozaki K., Chapoval A.I., Zhu G., Sica G., Flies D., Boone T., Hsu H., Fu Y.X., Nagata S., Ni J., Chen L. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat. Med. 2000, 6:283-289.
35. Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996, 85:291-297.
36. Toyoda H., Formby B. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model. Bioessays 1998, 20:750-757.
37. Vukkadapu S.S., Belli J.M., Ishii K., Jegga A.G., Hutton J.J., Aronow B.J., Katz J.D. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse. Physiol. Genomics 2005, 21:201-211.
38. Wang J., Foster A., Chin R., Yu P., Sun Y., Wang Y., Pfeffer K., Fu Y.X. The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function. Eur. J. Immunol. 2002, 32:1969-1979.
39. Wicker L.S., Todd J.A., Peterson L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 1995, 13:179-200.
40. Wu Q., Salomon B., Chen M., Wang Y., Hoffman L.M., Bluestone J.A., Fu Y.X. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J. Exp. Med. 2001, 193:1327-1332.
41. Wu S.F., Liu T.M., Lin Y.C., Sytwu H.K., Juan H.F., Chen S.T., Shen K.L., Hsi S.C., Hsieh S.L. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication. J. Leukoc. Biol. 2004, 75:293-306.
42. Wu Y., Han B., Luo H., Roduit R., Salcedo T.W., Moore P.A., Zhang J., Wu J. DcR3/TR6 effectively prevents islet primary nonfunction after transplantation. Diabetes 2003, 52:2279-2286.
43. Xu J.F., Xiao H., Hu G.Y., Zheng S.H., Liu W., Yuan C.L., Yang H., Lu J., Zheng F., Wang C.Y., Gong F.L. Ectopic B7-H4-Ig expression attenuates concanavalin A-induced hepatic injury. Clin. Immunol. 2010, 136:30-41.
44. You R.I., Chang Y.C., Chen P.M., Wang W.S., Hsu T.L., Yang C.Y., Lee C.T., Hsieh S.L. Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3). Blood 2008, 111:1480-1488.
45. Yu K.Y., Kwon B., Ni J., Zhai Y., Ebner R., Kwon B.S. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 1999, 274:13733-13736.
46. Zhang J., Salcedo T.W., Wan X., Ullrich S., Hu B., Gregorio T., Feng P., Qi S., Chen H., Cho Y.H., Li Y., Moore P.A., Wu J. Modulation of T-cell responses to alloantigens by TR6/DcR3. J. Clin. Invest. 2001, 107:1459-1468.